PMID- 31407591 OWN - NLM STAT- MEDLINE DCOM- 20200108 LR - 20200108 IS - 2169-141X (Electronic) IS - 2169-1401 (Linking) VI - 47 IP - 1 DP - 2019 Dec TI - Circular RNA ZFR accelerates non-small cell lung cancer progression by acting as a miR-101-3p sponge to enhance CUL4B expression. PG - 3410-3416 LID - 10.1080/21691401.2019.1652623 [doi] AB - BACKGROUND: Non-small-cell lung carcinoma (NSCLC) is the most common type of lung cancer. Circular RNA ZFR (circZFR) is an identified circular RNA (circRNA) that is correlated with cancer progression. However, the role of circZFR in NSCLC remains unknown. In the present study, we aimed to investigate the function of circZFR in NSCLC and the underlying mechanism. METHODS: The expression patterns of circZFR were determined using qRT-PCR in NSCLC samples and cell lines. The subcellular distribution of circZFR in NSCLC cells was analyzed by fluorescence in situ hybridization (FISH). Cell proliferation was examined utilizing the CCK-8 assay. Cell migration and invasion were evaluated using the Transwell assay. We used the bioinformatics software TargetScan and miRanda to predict circRNA-miRNA and miRNA-mRNA interactions. RESULTS: Our results showed that circZFR expressions were significantly upregulated in NSCLC tissues and cell lines. Knockdown of circZFR significantly inhibited the cell proliferation, migration and invasion of NSCLC cells in vitro. Furthermore, we demonstrated that circZFR acted as a sponge to absorb microRNA-101-3p (miR-101-3p) and promoted cullin 4B (CUL4B) expression. CONCLUSIONS: Collectively, our results demonstrated that circZFR exhibited a carcinogenic role by sponging miR-101-3p and regulating CUL4B expression in NSCLC. These findings provided evidence for understanding the role of circZFR in NSCLC tumourigenesis. FAU - Zhang, Haifeng AU - Zhang H AD - a Department of Thoracic Surgery, Huaihe Hospital of Henan University , Kaifeng , Henan , P. R. China. FAU - Wang, Xiaolong AU - Wang X AD - a Department of Thoracic Surgery, Huaihe Hospital of Henan University , Kaifeng , Henan , P. R. China. FAU - Hu, Baoli AU - Hu B AD - a Department of Thoracic Surgery, Huaihe Hospital of Henan University , Kaifeng , Henan , P. R. China. FAU - Zhang, Feng AU - Zhang F AD - a Department of Thoracic Surgery, Huaihe Hospital of Henan University , Kaifeng , Henan , P. R. China. FAU - Wei, Haitao AU - Wei H AD - a Department of Thoracic Surgery, Huaihe Hospital of Henan University , Kaifeng , Henan , P. R. China. FAU - Li, Li AU - Li L AD - b College of Nursing and Health, Henan University , Kaifeng , Henan , P. R. China. LA - eng PT - Journal Article PL - England TA - Artif Cells Nanomed Biotechnol JT - Artificial cells, nanomedicine, and biotechnology JID - 101594777 RN - 0 (CUL4B protein, human) RN - 0 (Cullin Proteins) RN - 0 (MIRN101 microRNA, human) RN - 0 (MicroRNAs) RN - 0 (RNA, Circular) SB - IM MH - Base Sequence MH - Carcinogenesis/genetics MH - Carcinoma, Non-Small-Cell Lung/*pathology MH - Cell Line, Tumor MH - Cell Movement/genetics MH - Cell Proliferation/genetics MH - Cullin Proteins/*genetics MH - *Disease Progression MH - Gene Expression Regulation, Neoplastic/*genetics MH - Gene Knockdown Techniques MH - Humans MH - Lung Neoplasms/*pathology MH - MicroRNAs/*genetics MH - Neoplasm Invasiveness MH - RNA, Circular/*genetics OTO - NOTNLM OT - Non-small-cell lung carcinoma (NSCLC) OT - cell proliferation OT - circular RNA ZFR (circZFR) OT - cullin 4B (CUL4B) OT - invasion OT - miR-101-3p EDAT- 2019/08/14 06:00 MHDA- 2020/01/09 06:00 CRDT- 2019/08/14 06:00 PHST- 2019/08/14 06:00 [entrez] PHST- 2019/08/14 06:00 [pubmed] PHST- 2020/01/09 06:00 [medline] AID - 10.1080/21691401.2019.1652623 [doi] PST - ppublish SO - Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3410-3416. doi: 10.1080/21691401.2019.1652623.